Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of rosuvastatin 20 mg in healthy Thai volunteers under fasting conditions
TCTR20170315001Completed
- Sponsor
- All Research
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rosuvastatin (2 arms), sponsored by All Research. Primary endpoints: Cmax at 72 hours, AUC0-t at 72 hours and 1 more. Started May 2017; status: completed.
02
Drugs
rosuvastatin
Beyond the preview
Go deeper on TCTR20170315001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170315001.